27/02/2024

Biotech recognised in regulation for Europe’s future: EuropaBio welcomes European Parliament’s vote on Strategic Technologies for Europe Platform Regulation

The European Parliament’s vote on Strategic Technologies for Europe Platform (STEP) represents an important first move to ensure European industry remains competitive and innovative. EuropaBio welcomes the inclusion of biotech according to the OECD definition as a strategic technology for Europe.
08/02/2024

EuropaBio welcomes and warns on New Genomic Techniques European Parliament vote

The New Genomic Techniques (NGTs) legislation vote in the European Parliament is a welcome modernisation of Europe’s biotechnology innovation, food security and climate change response. However, EuropaBio red flags the dangerous fragmentation and weakening of industrial policy with the ban on patenting of NGT plants.
07/02/2024

EuropaBio joins the PRIMED PROJECT CONSORTIUM

EuropaBio, the leading voice for the biotechnology industry in Europe, has joined the PRIMED (Redesigning the Primary Sector for Maximizing Bioeconomy Development) PROJECT CONSURTIUM, launched on January 12th, 2024, and supported by the European Union’s Horizon Europe Program.
01/12/2023

Agri-Food Chain Coalition launches EU Strategic Agenda 2024-2029

The Agri-Food Chain Coalition (AFCC) has published a recommendation for the EU Strategic Agenda 2024-2029 to include the strengthening of the European food autonomy and resilience as well as enhancing the competitiveness and sustainability of the entire EU-Agri food chain.
27/10/2023

EFIB Rotterdam Statement 2023

As the EU looks ahead to the European elections in 2024, with a new EU Commission mandate and Work Programme, EuropaBio reviews European strategies and ambitions where biotechnology plays a key role. Ursula von der Leyen’s State of the European Union address of 13 September announced an ‘EU Biotech and Biomanufacturing Initiative’ under the heading of ‘An Economy that Works for People’1. Europe needs to be ambitious for this, particularly when considering the ongoing changes in global perspective on biotechnology which were highlighted in the 2022 Vilnius Statement.